Ultrasonography, amniocentesis, fetoscopy, and more recently chorionic villus biopsy have led to an increase in the detection of fetal abnormalities and diseases. These techniques have encouraged a variety of direct interventions in utero for the correction of underlying defects. ' With the aim of obtaining a better understanding of normal fetal biochemistry we have studied the changes in commonly measured biochemical analytes relating to renal, hepatic, and bone function in fetal blood and their relation to maternal blood throughout gestation. This knowledge will enable a more rational approach to the diagnosis and treatment of conditions such as unexplained fetal hydrops, intrauterine growth retardation, and fetal obstructive uropathy. To this end, we have been able to analyse pure fetal blood samples obtained by fetoscopy' 2 from live fetuses in the second trimester of pregnancy and from cord blood at delivery. The batch was accepted only if the internal quality control values were within specified limits. Quality assessment was monitored with the use of two schemes, the United Kingdom External Quality Assurance Scheme (UKEQAS) and the Wellcome Group Quality Control Programme for Biochemical Indices. In the period during which the data were collected the running overall mean variance index score5 was never above 48%. In the Wellcome Reagent Group scheme, for the two year period under study, the variance index score (VIS) was used to calculate the mean VIS and standard deviation of VIS for each analyte. Using the published calculated coefficient of variation we were able to assess the percent accuracy and percent precision for each chemistry over a wide range of concentrations analysed in the two year period during which this study was undertaken (Table 2 ). Albumin was measured by turbimetry6 on the Cobas Bio Centrifugal analyser (Wellwyn Garden City), and performance was assessed using commercial controls (Armatrol).
Alkaline phosphatase isoenzymes in 12 cases were characterised by heat inactivation studies using 
Results and discussion
The results (mean and range) for each of the 11 biochemical analytes in fetal and maternal plasma are shown in Tables 3 and 4 respectively. In the analysis of variance of these data there is an overall change with gestational age in all substances measured except electrolytes (Table 5) . Analysis of variance on the difference in concentration in substances in maternal and fetal plasma with gestation show that these overall changes in the two compartments occur independently (Table 6 ).
ELECTROLYTES
Sodium and potassium concentrations in both fetal and maternal plasma showed no change with gestational age. These results indicate that the developing fetus is remarkably efficient in maintaining the electrolyte concentration of it's plasma constant Moniz, Nicolaides, Bamforth, Rodeck There was an overall significant increase in the concentration of urea and creatinine in fetal plasma, but when the changes were examined in individual gestational groups the concentrations were not different in the two compartments until 20-22 weeks' gestation (t = 0 4, p > 0 05, paired Student's t test). In animal studies, fetal plasma urea concentrations were higher than maternal values, with a constant fetal-maternal concentration gradient across the placenta, over a wide range of urea concentrations." It is possible that creatinine, like urea, also has a constant diffusion rate and the rise in fetal plasma creatinine reflects the increases in fetal muscle mass rather than a decrease in renal function. In addition, account must be taken of non-creatinine reacting substances in plasma'2 that could contribute significantly in the assay of creatinine, particularly at low values. Maternal plasma urea and creatinine 3 .5 (3-4-3-7) 3.4 (2-7-4 (3-2-3-6) 3.1 Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function Table 5 Analysis of variance ofbiochemical analytes using xI for the six gestational groups shown in Tables 3 and 4 Test (Figs. 1 and 2 ). Indeed the concentration of plasma proteins in the fetal circulation increased by more than half during gestation. evidence that fetal a-fetoprotein synthesis is decreasing at this time20 and it is likely that albumin synthesis is switched on to become the major plasma protein in the circulation.
ASPARTATE TRANSAMINASE AND BILIRUBIN
These substances that reflect hepatic function were low in maternal blood throughout pregnancy. There were, however, small increases in fetal plasma, which in the case of aspartate transaminase could be due to leakage of this cytoplasmic enzyme from hepatic cells or else due to high concentrations of pyruvate in fetal blood which would consume NADH in the assay. When considering the causes of hyperbilirubinaemia, the life of the erythrocyte, the space in which bilirubin is distributed, as well as the glucuronide conjugating ability of the liver have to be taken into account. Fetal erythrocytes have a shortened life span of about 70 days21 and the liver conjugating ability is still immature. In this study the normal values of commonly measured biochemical substances relating to hepatic, renal, and bone function have been established in pure fetal blood samples. The concentrations of substances in blood at the time of sampling depend on a variety of factors, such as production and elimination rates and fluid distribution. Nevertheless, these values may be used as a reference range for pathophysiological investigations.
